(Q45758375)

15 December 2017

title

Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells (English)

1 reference

15 December 2017

author name string

Xue Dong

1

1 reference

15 December 2017

Lu-Gang Yu

2

1 reference

15 December 2017

Rong Sun

3

1 reference

15 December 2017

Yan-Na Cheng

4

1 reference

15 December 2017

Hua Cao

5

1 reference

15 December 2017

Kang-Min Yang

6

1 reference

15 December 2017

Yi-Ning Dong

7

1 reference

15 December 2017

Yan Wu

8

1 reference

15 December 2017

Xiu-Li Guo

9

1 reference

15 December 2017

publication date

1 January 2013

1 reference

15 December 2017

Journal of Cellular Biochemistry

published in

1 reference

15 December 2017

volume

114

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

174-182

1 reference

15 December 2017

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

cites work

1 reference

Focal adhesion kinase: a promising target for anticancer therapy

21 January 2018

1 reference

The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation

21 January 2018

1 reference

Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.

21 January 2018

1 reference

Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN

21 January 2018

1 reference

PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis

21 January 2018

1 reference

The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-kappaB-inducing kinase pathways: role of H(2)O(2) in NF-kappaB activation

21 January 2018

1 reference

The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness

21 January 2018

1 reference

Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways

21 January 2018

1 reference

Reversible inactivation of the tumor suppressor PTEN by H2O2

21 January 2018

1 reference

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

21 January 2018

1 reference

Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits

21 January 2018

1 reference

Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.

21 January 2018

1 reference

Cardiac regulation by phosphoinositide 3-kinases and PTEN

21 January 2018

1 reference

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

21 January 2018

1 reference

Protective effect of an antioxidative peptide purified from gastrointestinal digests of oyster, Crassostrea gigas against free radical induced DNA damage

21 January 2018

1 reference

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

21 January 2018

1 reference

21 January 2018

New insights into PTEN.

1 reference

Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells

21 January 2018

1 reference

Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma

21 January 2018

1 reference

Regulation of Akt by arachidonic acid and phosphoinositide 3-kinase in angiotensin II-stimulated vascular smooth muscle cells

21 January 2018

1 reference

Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway

21 January 2018

1 reference

PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24315

1 reference

15 December 2017

1 reference

15 December 2017